Saturday, November 28, 2015 9:36:18 AM
Could Tapimmune be the right place?
Coincidentally Glynn has hinted on at least 2 occasions that they were going to announce a collaboration with not only a large BP but a cancer institute as well.
Just wondering if there may be a nice grant from the Cancer Institute, when they announce who those two collaborations are with.
After all the Institute has spent 5 billion in the "wrong places" as per the video, a nice 10 million or so grant may not be out of the question at all.
Glynn mentioned in the last CC that they are expecting a grant any time soon...seems to me to be quite a coincidence.
If they get involved, would be great to see then fund the HER2Nue trial and if they do come on board, may continue to fund till end of trials if the data continues to be stellar.
Remember folks they are nearing completion of the "commercial" vaccine which is supposed to be much more effective than the Phase 1 data vaccine.
As to the suppression of SP due to the warrants, most of us know this is at least a 2 year window "patience" the momentum is swinging our way.
I will reiterate, would not be surprised at all that with 2 Phase 11 trials up and running [mid 2016], grant funding, partnership with large BP and institute possible [funding], continued non-recurrence of disease, and Polystart Phase 1 initiation, and no debt and cash in bank, fast track status etc. That we do not receive one if not multiple offers to purchase the company.
Glynn looks quite excited in the video with Figueredo, each and every step of the way so far, they have accomplished, and exceeded their goal[s] .
The Tapimmune story is substantially better than the prior 2 companies that were bought out for 1 billion plus, scenario once again, 100 mill O/S [min possibly 120 max] within the mid 2016 timeframe $10 dollars plus. There may be a very real possibility of that scenario coming to fruition.
Would be great to see those sequence of events occur without a R/S, but if R/S does occur than with the reduced amount of shares and Dart's overwhelming ownership. SP mid 2016 should after up-listing to major exchange garner a much higher SP than $10.
Is it out of the question that Dart buys the company?
Let the bidding wars begin as the announcer says "For the first time ever, a Palm Beach County doctor is on the verge of one of the biggest medical breakthroughs of the century".
GLTA
BLU
Recent MRKR News
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:03:53 PM
- Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 11:10:46 AM
- Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse • GlobeNewswire Inc. • 09/11/2023 11:00:00 AM
- Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2023 12:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:37:04 PM
- Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2023 08:30:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:03:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 11:22:44 AM
- Marker Therapeutics Reports Non-Clinical Proof-of-Concept Data and Update on Clinical Readiness for the MT-401 Off-the-Shelf Program • GlobeNewswire Inc. • 08/07/2023 11:00:17 AM
- Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023 • GlobeNewswire Inc. • 07/26/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 11:09:50 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM